Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Jul 04, 2026
Faut-il acheter du Bitcoin alors qu'il est inférieur à 70 000 $ ?
Should You Buy Bitcoin While It's Below $70,000?
The panel's net takeaway is that Bitcoin's price trajectory is uncertain, with risks including miner selling, regulatory disappointment, and potential …
City & Guilds confrontée à des actions judiciaires et syndicales concernant ses projets de suppression de centaines d'emplois
City & Guilds faces legal and industrial action over plans to cut hundreds of jobs
The panel consensus is that PeopleCert's planned workforce cuts at City & Guilds pose significant operational and regulatory risks, potentially …
Ce qui se cache derrière la chute des résultats de Palo Alto — et comment procéder
What's behind Palo Alto's earnings sell-off — and how to proceed
Palo Alto Networks' earnings beat and forward guidance were overshadowed by valuation concerns, with the stock dropping despite the positive …
Une stratégie classique qui pourrait rapporter gros
A classic strategy that could yield big dividends
The panel generally agreed that the covered-call strategy on PKG is risky and may not be suitable given the cyclical …
Les actions de Marvell atteignent un sommet historique après que Huang d'Nvidia les ait qualifiées de « prochaine entreprise du mille milliards de dollars »
Marvell shares touch record high after Nvidia's Huang calls it 'next trillion-dollar company'
Despite the bullish sentiment driven by AI demand and Nvidia's endorsement, the panel consensus is neutral due to execution risks, …
Faut-il convertir 130 000 $ par an en Roth pour éviter les RMD ? J'ai 59 ans avec 1,3 million de dollars dans un 401(k)
Should I Convert $130,000 a Year to a Roth to Avoid RMDs? I'm 59 With $1.3 Million in a 401(k)
The panel generally agreed that Roth conversions, as presented in the article, come with significant risks and complexities that are …
Comment La Performance Boursière De Gilead Sciences Se Compare-t-elle Aux Autres Actions de Santé
How Is Gilead Sciences's Stock Performance Compared to Other Healthcare Stocks
The panel consensus is bearish on Gilead Sciences (GILD) due to concerns about Sunlenca uptake, payer pressure on HIV drug …
Activité Notable en Matière d'Options le Mercredi : WDC, TMUS, SCHW
Notable Wednesday Option Activity: WDC, TMUS, SCHW
The panel discusses elevated options volume in TMUS and SCHW, interpreting it as long-term institutional positioning rather than short-term speculation. …
Devriez-vous acheter l'action Micron avant le 24 juin ? L'histoire a une réponse claire.
Should You Buy Micron Stock Before June 24? History Has a Clear Answer.
The panel consensus is bearish on Micron (MU) due to the stock's high valuation for a cyclical commodity business and …
Rapport quotidien sur les dividendes : MDT, ACM, UNH, RICK, VRT
Daily Dividend Report: MDT,ACM,UNH,RICK,VRT
The panelists generally agreed that the dividend declarations signal stability but lack detail on durability, with key risks including regulatory …
Les détenteurs de Bitcoin les plus convaincus se transforment en vendeurs alors que le prix de la crypto atteint de nouveaux plus bas
Bitcoin's high conviction holders are turning into sellers as the crypto's price hits new lows
The panel consensus is bearish, with key risks identified as persistent negative ETF flows, lack of regulatory catalysts, and potential …
Le titre Amphenol surperforme-t-il le Nasdaq ?
Is Amphenol Stock Outperforming the Nasdaq?
The panel's discussion on Amphenol (APH) highlights potential risks that may not be fully reflected in its current valuation. While …